Documents

DEA's revised and updated drug fact sheet about a drug known as hydromorphone - what it is, what is its origin, what are its common street names, what it looks like, how it is abused, what its effect is on the mind and bodies of users including signs of overdose, and its legal status. 

DEA's revised and updated drug fact sheet about heroin - what it is, what is its history, what are its common street names, what it looks like, how it is abused, what its effect is on the mind and bodies of users including signs of overdose, and its legal status. 

DEA's revised and updated drug fact sheet about the class of drugs known as hallucinogens - what are they, what their origin is, what are the common street names for these drugs, what do they look like, how they are abused, what their effect is on the mind and bodies of users including signs of overdose, and their legal status. 

DEA's revised and updated drug fact sheet about the drug known as GHB - what it is, what is its origin, what are its common street names, what does it look like, how it is abused, what its effect is on the mind and bodies of users including signs of overdose, and its legal status. 

DEA's revised and updated drug fact sheet about the class of drugs known as fentanyls - what are they, what their origin is, what are the common street names for these drugs, what do they look like, how they are abused, what their effect is on the mind and bodies of users including signs of overdose, and their legal status. 

DEA's revised and updated drug fact sheet about MDMA, also known as ecstasy - what it is, what is its origin, what common street names for these drugs, what does it look like, how it is abused, what their effect is on the mind and bodies of users including signs of overdose, and its legal status. 

DEA's revised and updated drug fact sheet about the drug known as DXM - what is it, what is its origin, what are common street names , what does it look like, how it is abused, what its effect is on the mind and bodies of users including signs of overdose, and its legal status. 

DEA's revised and updated drug fact sheet about the class of drugs known as depressants - what are they, what their origin is, what are the common street names for these drugs, what do they look like, how they are abused, what their effect is on the mind and bodies of users including signs of overdose, and their legal status. 

DEA's revised and updated drug fact sheet about cocaine - what it is, its origin, what are common street names, what does it look like, how it is abused, what its effect is on the mind and bodies of users including signs of overdose, and its legal status. 

DEA's revised and updated drug fact sheet about the class of drugs known as benzodiazepines (tranquilizers) - what are they, what their origin is, what are the common street names for these drugs, what do they look like, how they are abused, what their effect is on the mind and bodies of users including signs of overdose, and their legal status. 

DEA's revised and updated drug fact sheet about synthetic stimulants known by the street name "bath salts" - what are they, what is their origin, what are the common street names for these drugs, what do they look like, how are they abused, what their effect is on the mind and bodies of users including signs of overdose, and their legal status. 

DEA's revised and updated drug fact sheet about the class of drugs known as barbiturates - what are they, what is their origin, what are the common street names for these drugs, what do they look like, how are they abused, what their effect is on the mind and bodies of users including signs of overdose, and their legal status. 

DEA's revised and updated drug fact sheet about the class of drugs known as amphetamines - what are they, what is their origin, what are the common street names for these drugs, what do they look like, how are they abused, what their effect is on the mind and bodies of users including signs of overdose, and their legal status. 

This document is an internal Drug Enforcement Administration quality system document for latent print examination.  The document is updated periodically and current as of May 15, 2020 and is provided for informational purposes only. Any sensitive, privileged or otherwise protected information has been redacted, to include the redaction of some documents in their entirety. All redactions are clearly present in this document. Names of commercial manufacturers are provided for identification only and inclusion does not imply endorsement by the Drug Enforcement Administration.

Drugs of Abuse delivers clear, scientific information about drugs in a factual, straightforward way. With the information in this guide, parents and caregivers can help their children make smart choices and avoid the consequences of drug abuse. This publication covers topics including the Controlled Substances Act and introduces drug classes including narcotics, stimulants, marijuana/cannabis, inhalants, steroids, and more. 

The Drug Enforcement Administration is adjusting the 2020 aggregate production quotas for certain controlled substances in schedule II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine and pseudoephedrine. This increase is in response to the current nationwide COVID-19 public health emergency as declared by the Secretary of Health and Human Services on January 31, 2020.

The flow of fentanyl into the United States in 2019 is more diverse compared to the start of the fentanyl crisis in 2014, with new source countries and new transit countries emerging as significant trafficking nodes. This is exacerbating the already multi-faceted fentanyl crisis by introducing additional source countries into the global supply chain of fentanyl, fentanyl-related substances, and fentanyl precursors. Further, this complicates law enforcement operations and policy efforts to stem the flow of fentanyl into the United States. While Mexico and China are the primary source countries for fentanyl and fentanyl-related substances trafficked directly into the United States, India is emerging as a source for finished fentanyl powder and fentanyl precursor chemicals.

Statement of Thomas Prevoznik Deputy Assistant Administrator Diversion Control Division Drug Enforcement Administration U.S. Department of Justice Before the Subcommittee on Health House Committee on Energy and Commerce U.S. House of Representatives at a hearing entitled “Combatting an epidemic: legislation to help patients with substance use disorders” presented March 3, 2020

The DEA New Orleans Division conducted a five-year review of the data on synthetic substances reported in the National Forensic Laboratory Information System for their area of responsibility. The findings revealed that Louisiana submitted the majority of reports for synthetic cannabinoid substance and synthetic cathinones substance for 2013 to 2017. Synthetic cannabinoid substance and synthetic cathinones are classified as new psychoactive substances (NPS).